Financhill
Back

Cardlytics Quote, Financials, Valuation and Earnings

Cardlytics Price Quote

$3.93

Cardlytics Key Stats

Buy
60
Cardlytics (CDLX) is a Buy

Day range:
$3.81 - $4.05
52-week range:
$2.89 - $20.52
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.61
P/B ratio:
2.87%

Volume:
532.8K
Avg. volume:
861.2K
1-year change:
-49.87%
Market cap:
$199.7M
Revenue:
$309.2M
EPS:
$-6.29

How Much Does Cardlytics Make?

  • How Much Are Cardlytics's Sales Annually?
    CDLX Revenues are $309.2M
  • How Much Profit Does Cardlytics's Make A Year?
    CDLX net income is -$134.7M

Is Cardlytics Growing As A Company?

  • What Is Cardlytics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.15%
  • What Is Cardlytics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cardlytics Stock Price Performance

  • Did Cardlytics Stock Go Up Last Month?
    Cardlytics share price went up by 0.26% last month
  • Did CDLX's Share Price Rise Over The Last Year?
    CDLX share price fell by -49.87% over the past 1 year

What Is Cardlytics 52-Week High & Low?

  • What Is Cardlytics’s 52-Week High Share Price?
    Cardlytics has traded as high as $20.52 over the past 52 weeks
  • What Is Cardlytics’s 52-Week Low Share Price?
    Cardlytics has traded as low as $2.89 over the past 52 weeks

Cardlytics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cardlytics?

  • How Much Debt Does Cardlytics Have?
    Total long term debt quarterly is $213.2M
  • How Much Cash Does Cardlytics Have?
    Cash and short term investments quarterly total is $67M
  • What Is Cardlytics’s Book Value Per Share?
    Book value per share is 1.38

Is Cardlytics Cash Flow Positive?

  • What Is CDLX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.9M
  • What Is Cardlytics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.7M
  • What Is Cardlytics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$16M

Cardlytics Return On Invested Capital

  • Is Management Doing A Good Job?
    CDLX return on invested capital is -67.37%
  • What Is Cardlytics Return On Assets?
    ROA measures how assets are converting to revenues and is -50.62%
  • What Is CDLX Return On Equity?
    ROE is a measure of profitability and is -163.62%

Cardlytics Earnings Date & Stock Price

  • What Is Cardlytics's Stock Price Today?
    A single share of CDLX can be purchased today for 3.93
  • What Is Cardlytics’s Stock Symbol?
    Cardlytics trades on the nasdaq under the ticker symbol: CDLX
  • When Is Cardlytics’s Next Earnings Date?
    The next quarterly earnings date for Cardlytics is scheduled on March 14, 2025
  • When Is CDLX's next ex-dividend date?
    Cardlytics's next ex-dividend date is November 24, 2024
  • How To Buy Cardlytics Stock?
    You can buy Cardlytics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cardlytics Competitors

  • Who Are Cardlytics's Competitors?
    Below is a list of companies who compete with Cardlytics or are related in some way:
    • Dolphin Entertainment Inc (DLPN)
    • Lendway Inc (LDWY)
    • Magnite Inc (MGNI)
    • Travelzoo (TZOO)
    • Ziff Davis Inc (ZD)

Cardlytics Dividend Yield

  • What Is CDLX Dividend Yield?
    Cardlytics’s dividend yield currently is 0%
  • What Is Cardlytics’s Payout Ratio?
    Cardlytics’s payout ratio is 0%
  • When Did Cardlytics Last Pay A Dividend?
    The latest dividend pay date is November 24, 2024
  • What Is Cardlytics’s Dividend Per Share?
    Cardlytics pays a dividend of $0.00 per share

Cardlytics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 43.75%
Revenue: -15.12% 16.48%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 4.40
Upside from Last Price: 11.96%

Major Shareholders

  • How many CDLX shares are owned by institutional investors?
    50.3M CDLX shares are owned by institutional investors
  • How many CDLX shares are owned by insiders?
    2M CDLX shares are owned by insiders